Reported 1,819,104 shares, up 4,407 (0.2%) from the prior quarter.
Reported value 36.9%; share count 0.2% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-03-31 | 8965000 |
| 2022-06-30 | 7386000 |
| 2022-09-30 | 5843000 |
| 2022-12-31 | 14499429 |
| 2023-03-31 | 13392464 |
| 2023-06-30 | 18336569 |
| 2023-09-30 | 68585 |
| 2023-12-31 | 65729 |
| 2024-03-31 | 4743685 |
| 2024-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2024 | Reduced | 0 | -450,065 (-100.0%) | 0 | $0 | 2024-08-13 | |
| Q1 2024 | Added | 450,065 | +444,212 (7589.5%) | 0.02% | $4,743,685 | 2024-05-13 | |
| Q4 2023 | Reduced | 5,853 | -19 (-0.3%) | < 0.01% | $65,729 | 2024-02-13 | |
| Q3 2023 | Reduced | 5,872 | -1,813,232 (-99.7%) | < 0.01% | $68,585 | 2023-11-13 | |
| Q2 2023 | Added | 1,819,104 | +4,407 (0.2%) | 0.11% | $18,336,569 | 2023-08-04 | |
| Q1 2023 | Unchanged | 1,814,697 | 0 (0.0%) | 0.09% | $13,392,464 | 2023-05-12 | |
| Q4 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.1% | $14,499,429 | 2023-02-10 | |
| Q3 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.04% | $5,843,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 1,814,697 | 0 (0.0%) | 0.05% | $7,386,000 | 2022-08-12 | |
| Q1 2022 | New | 1,814,697 | +1,814,697 (0.0%) | 0.05% | $8,965,000 | 2022-05-13 |
Who else reported the position
205 managers reported ROIVANT SCIENCES LTD for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| QVT Financial LP | Unchanged | 122,541,536 | 0 | 67.65% | $1,235,218,683 | 7 qtrs |
| SB INVESTMENT ADVISERS UK LTD | Unchanged | 83,031,667 | 0 | 6.38% | $836,959,203 | 7 qtrs |
| VIKING GLOBAL INVESTORS LP | Reduced | 75,238,700 | -13,000,000 | 3.1% | $758,406,096 | 7 qtrs |
| FMR LLC | Added | 35,997,134 | +5,234,850 | 0.03% | $362,851,111 | 7 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Added | 15,196,555 | +3,167,758 | 0.03% | $153,181,275 | 2 qtrs |
| MORGAN STANLEY | Added | 12,986,716 | +9,810,452 | 0.01% | $130,906,099 | 7 qtrs |
| Patient Square Capital LP | Added | 12,639,920 | +5,813,953 | 62.03% | $127,410,394 | 3 qtrs |
| BlackRock Inc | Added | 12,372,873 | +6,170,264 | < 0.01% | $124,718,560 | 7 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Reduced | 11,090,300 | -3,790,625 | 0.24% | $111,790,224 | 5 qtrs |
| STATE STREET CORPORATION | Added | 9,533,896 | +1,500,944 | < 0.01% | $96,101,672 | 7 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 04, 2023
- Filing type
- 13F-HR
- Position type
- SHS
Voting authority reported
- Sole
- 1,819,104
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.